"Platinum Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inorganic compounds which contain platinum as the central atom.
| Descriptor ID |
D017671
|
| MeSH Number(s) |
D01.710
|
| Concept/Terms |
Platinum Compounds- Platinum Compounds
- Compounds, Platinum
- Platinum Compounds, Inorganic
- Compounds, Inorganic Platinum
- Inorganic Platinum Compounds
|
Below are MeSH descriptors whose meaning is more general than "Platinum Compounds".
Below are MeSH descriptors whose meaning is more specific than "Platinum Compounds".
This graph shows the total number of publications written about "Platinum Compounds" by people in this website by year, and whether "Platinum Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 6 | 9 |
| 2018 | 1 | 2 | 3 |
| 2019 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Platinum Compounds" by people in Profiles.
-
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases. Eur J Surg Oncol. 2019 Nov; 45(11):2096-2102.
-
Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trial. Lung Cancer. 2019 06; 132:17-23.
-
Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial. Clin Lung Cancer. 2019 05; 20(3):e413-e417.
-
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study. J Geriatr Oncol. 2019 07; 10(4):591-597.
-
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum. Lung Cancer. 2018 04; 118:90-96.
-
Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapy. Lung Cancer. 2018 03; 117:64-69.
-
Impact of Primary Tumor Location on Survival from the European Organization for the Research and Treatment of Cancer Advanced Urothelial Cancer Studies. J Urol. 2018 05; 199(5):1149-1157.
-
The expression of miRNAs is associated with tumour genome instability and predicts the outcome of ovarian cancer patients treated with platinum agents. Sci Rep. 2017 11 07; 7(1):14736.
-
Optimizing treatment in recurrent epithelial ovarian cancer. Expert Rev Anticancer Ther. 2017 12; 17(12):1147-1158.
-
Retrospective study of hypersensitivity reactions to chemotherapeutic agents in a thoracic oncology service. J Clin Pharm Ther. 2018 Jun; 43(3):320-326.